These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 19999284)
1. Regulation of smoking cessation drugs by the Food and Drug Administration. Richins C Food Drug Law J; 2009; 64(2):277-90. PubMed ID: 19999284 [TBL] [Abstract][Full Text] [Related]
2. Treatment of nicotine dependence with Chantix (varenicline). Rankin KV; Jones DL Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368 [TBL] [Abstract][Full Text] [Related]
7. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand. Harrison-Woolrych M; Ashton J Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):949-53. PubMed ID: 20602347 [TBL] [Abstract][Full Text] [Related]
8. Smoking cessation: an overview of treatment options with a focus on varenicline. Stack NM Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463 [TBL] [Abstract][Full Text] [Related]
9. The FDA approves new drug for smoking cessation. FDA Consum; 2006; 40(4):29. PubMed ID: 17243286 [TBL] [Abstract][Full Text] [Related]
10. Varenicline for smoking cessation. Harrison-Woolrych M BMJ; 2012 Nov; 345():e7547. PubMed ID: 23138037 [No Abstract] [Full Text] [Related]
13. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. Toh S; Baker MA; Brown JS; Kornegay C; Platt R; JAMA Intern Med; 2013 May; 173(9):817-9. PubMed ID: 23529063 [No Abstract] [Full Text] [Related]
14. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789 [TBL] [Abstract][Full Text] [Related]
15. New kid on the block: Chantix for smoking cessation. Rankin KV Tex Dent J; 2008 May; 125(5):432-3. PubMed ID: 18561798 [No Abstract] [Full Text] [Related]
16. [Medications for smoking cessation. New advice concerning important neuropsychiatric effects]. Sabourin G Perspect Infirm; 2010; 7(1):55. PubMed ID: 20120183 [No Abstract] [Full Text] [Related]
17. [Varenicline--a new chance for smokers?]. Goniewicz ML; Koszowski B; CzogaĆa J; Sobczak A Przegl Lek; 2007; 64(10):899-902. PubMed ID: 18409337 [TBL] [Abstract][Full Text] [Related]